ÌÇÐÄÆƽâ°æ

Compound annual growth rate (CAGR) of private healthcare investment in Asia from 2019 to 2024, by segment

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

January 2025

Region

Asia, APAC

Survey time period

2019 to 2024

Special properties

excluding China, Japan, South Korea, Australia, and New Zealand

Supplementary notes

The analysis is based on approximately 5,100 companies in the healthcare services sector, identified through keyword-based searches on Quid. These companies were either founded since 2010 or received funding since August 2019, and are located in APAC markets (excluding China, Japan, South Korea, Australia, and New Zealand). The companies were grouped according to similarities in products, technologies, customers, service offerings, and other relevant factors.

Citation formats

CAGR of private healthcare investment Asia 2019-2024, by segment

Published by K. Scholle, Feb 19, 2025

Between 2019 and 2024, private investment in the digital health segment in Asia (excluding China, Japan, South Korea, Australia, and New Zealand) grew at a compound annual growth rate (CAGR) of about *** percent. During this period, private investment in the medical technology segment in the region grew at a CAGR of about ** percent.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Southeast Asia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Southeast Asia

SEA overview

4

OTC pharmaceuticals

4

Clinical trials

3

Overview

5

International trade

5

Investment

3

Further Content: You might find this interesting as well

Topics

Medical technology in the Asia-Pacific regionMedical technologyDigital healthSmart wearables in the Asia-Pacific regionState of health in the Asia-Pacific region
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.